Harvard Health Publishing: Men with intermediate-risk prostate cancer may benefit from undergoing androgen-deprivation therapy (ADT).
Men with intermediate-risk prostate cancer may benefit from undergoing androgen-deprivation therapy (ADT) depending on how far the cancer has progressed, says a study published online Sept. 9, 2020, by JAMA Network Open. The results could help men better weigh risk versus reward when choosing their prostate cancer treatment options. READ MORE
(Source: Harvard Health Publishing, 12/01/2020)